MIRXES-B
0262912.4100.00% ( 0.000 )
MIRXES-B (02629)
Mirxes Holding Company Limited, a micro ribonucleic acid technology company, provides diagnostic solutions for the screening of cancer, cardiovascular, metaboli...
- Open
- 12.410
- High
- 12.410
- Low
- 12.410
- Prev. Close
- 12.410
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- 0.00%
- 52wk High
- 77.300
- Volume Ratio
- 0.00
- Turnover Ratio
- --
MIRXES-B Analyst Rating
View MoreForecast & Rating
Sep 18, 2025Price forecast
HK$99.98705.64%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · Aug 1 at 04:14 AM
China Taiping's Profit Surge and CICC Merger Rumors Highlight This Week's Market Moves
- Global Report · Jul 22 at 04:18 AM
Hong Kong Mid-Caps Drive Summer Dealmaking Amid USD 2.3 Billion Bio-Licensing and Stock Buybacks
- AASTOCKS News · Jul 9 at 10:20 PM
RIGOL , DTECH , BEFAR GROUP Added to Southbound Stock Connect List
- Tip Ranks · Jul 1 at 06:37 AM
Mirxes updates investors on trading resumption efforts and ongoing forensic probe
- PUBT · Jul 1 at 06:32 AM
Mirxes faces outstanding audit matters, delays 2025 annual results publication
- Tip Ranks · May 10 at 07:07 AM
Mirxes Faces Ongoing Trading Suspension as Auditors Probe Prepayments and Large Cash Outflows
